Clinical Trial Update: HD12 for Advanced Stages [Phase 3]

View source ↗

Summary

Clinical trial HD12, a Phase 3 study for advanced Hodgkin lymphoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin´s Lymphoma | Phase 3 | Status: COMPLETED